Michael Kelly - Net Worth and Insider Trading

Michael Kelly Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Kelly owns 2 companies in total, including Silverback Therapeutics Inc (SBTX) , and ARS Pharmaceuticals Inc (SPRY) .

Click here to see the complete history of Michael Kelly’s form 4 insider trades.

Insider Ownership Summary of Michael Kelly

Ticker Comapny Transaction Date Type of Owner
SBTX Silverback Therapeutics Inc 2022-11-08 director
SPRY ARS Pharmaceuticals Inc 2022-11-08 director

Michael Kelly Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Kelly Ownership Network

Ownership Network List of Michael Kelly

No Data

Ownership Network Relation of Michael Kelly

Insider Network Chart

Michael Kelly Owned Company Details

What does Silverback Therapeutics Inc do?

Who are the key executives at Silverback Therapeutics Inc?

Michael Kelly is the director of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and director & 10 percent owner & other: * Director by deputization Deerfield Management Company, L.p. (series C) .

Silverback Therapeutics Inc (SBTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Silverback Therapeutics Inc Insider Transactions

No Available Data

Michael Kelly Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Kelly. You might contact Michael Kelly via mailing address: C/o Ars Pharmaceuticals, Inc., 11682 El Camino Real, Suite 120, San Diego Ca 92130.